Eastvale, CA, United States of America

Alexander J Kim



 

Average Co-Inventor Count = 14.1

ph-index = 3

Forward Citations = 19(Granted Patents)


Location History:

  • Philadelphia, PA (US) (2006)
  • Morganville, NJ (US) (2014 - 2017)
  • Eastvale, CA (US) (2018 - 2019)
  • Rahway, NJ (US) (2019)

Company Filing History:


Years Active: 2006-2019

where 'Filed Patents' based on already Granted Patents

7 patents (USPTO):

Title: Innovations in Cancer Treatment: The Contributions of Inventor Alexander J. Kim

Introduction: Alexander J. Kim, an accomplished inventor based in Eastvale, CA, has made significant contributions to the field of medical science with a focus on innovative treatments for cancer. With a total of seven patents to his name, Kim's research and inventions are centered around advanced pharmaceutical compounds that target specific enzymes involved in cancer progression.

Latest Patents: Among his notable patents, one of the latest is centered on tricyclic compounds designed as inhibitors of mutant IDH enzymes. These compounds, represented by a specific formula, play a critical role in inhibiting one or more mutant IDH enzymes that are linked to various cancers. The invention encompasses not only the compounds themselves but also their potential applications in the treatment and prevention of cancers associated with these mutant enzymes. Additionally, the patent details compositions that include these compounds, aimed at advancing therapies that could yield significant improvements in patient outcomes.

Career Highlights: Throughout his career, Alexander J. Kim has worked with prominent pharmaceutical companies such as Merck Sharp & Dohme Corporation. His dedication to research and innovation is evident in his extensive patent portfolio, reflecting his commitment to developing effective cancer therapies.

Collaborations: In his journey as an inventor, Kim has collaborated with distinguished colleagues, including Dann LeRoy Parker, Jr., and Guizhen Dong. These collaborations have facilitated the exchange of ideas and further innovations in the realm of pharmaceutical development.

Conclusion: Alexander J. Kim's innovative work in creating tricyclic compounds as inhibitors of mutant IDH enzymes represents a promising advancement in the field of cancer treatment. With a robust patent portfolio and valuable collaborations, Kim continues to contribute to medical science, demonstrating the powerful impact that dedicated inventors can have on improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…